ソース | 28 |
|---|---|
24時間取引高 | $114.44 |
流動性 | $2,073.8 |
ホルダー | 90 |
監査情報 | |
年齢 | 3 日 |
FDV | $1,990.8 |
時価総額 | $1,990.8 |
Moderna Inc (mRNA)
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.
トークン情報を更新するmRNA/SOL 価格統計
mRNA (mRNA/SOL) のPumpSwapでの現在の価格は$0.000001991です。過去24時間で -1.34%上昇しました。24時間取引高は $114.44で、合計トランザクション数は 3と報告されています。mRNA/SOLのコントラクトアドレスは 8PuiDczBmQuTHtwK4YjtRsViQ74hE2jKZY4ib7wrfxN2で、完全希薄化後評価額 (FDV) は$1,990.76、流動性プールは $2,073.79です。
